Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HaloLaser Biotherapy was a Texas-based biotechnology company specializing in alternative pain management and medical laser technology. The company was the primary distributor of the NeuroLase 150 Medical Laser, an FDA-approved device designed to treat acute muscle and skeletal pain as well as arthritis. Founded in 2001 as NutriHealth Marketing, it rebranded to HaloLaser Biotherapy before undergoing a reverse merger with BioTech Medics, Inc. in December 2004. Following the acquisition, its operations were integrated into BioTech Medics' broader portfolio of medical and nutraceutical products. The company's approach combined advanced laser therapy with clinical expertise in physical medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HaloLaser Biotherapy.